1. Home
  2. GRDX vs MIND Comparison

GRDX vs MIND Comparison

Compare GRDX & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GridAI Technologies Corp.

GRDX

GridAI Technologies Corp.

HOLD

Current Price

$3.22

Market Cap

33.2M

Sector

Health Care

ML Signal

HOLD

Logo MIND Technology Inc. (DE)

MIND

MIND Technology Inc. (DE)

HOLD

Current Price

$2.42

Market Cap

29.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRDX
MIND
Founded
N/A
1987
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
33.2M
29.7M
IPO Year
2016
1997

Fundamental Metrics

Financial Performance
Metric
GRDX
MIND
Price
$3.22
$2.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 147.2K
64.0K
Earning Date
11-16-2026
12-08-2026
Dividend Yield
N/A
N/A
EPS Growth
21.95
★ 29.77
EPS
N/A
★ N/A
Revenue
N/A
★ $42,675,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$73.65
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.87
$2.53
52 Week High
$6.93
$11.39

Technical Indicators

Market Signals
Indicator
GRDX
MIND
Relative Strength Index (RSI) 36.24 18.86
Support Level $3.23 N/A
Resistance Level $4.19 $4.78
Average True Range (ATR) 0.79 0.25
MACD -0.26 -0.08
Stochastic Oscillator 26.36 1.24

Price Performance

Historical Comparison
GRDX
MIND

About GRDX GridAI Technologies Corp.

GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in single segment namely, Seamap which provides services and products, including engineering, repairs and software licensing, utilized in marine exploration, marine survey and maritime security for marine survey companies, seismic survey contractors, research institutes, non-military government organizations and operators of port facilities and other offshore installations. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.

Share on Social Networks: